newsfilter
← Latest News
GlobeNewswire·

University of Pennsylvania's School of Veterinary Medicine to Evaluate New Gastrointestinal Panel Using LexaGene's MiQLab System

BEVERLY, Mass., Aug. 17, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), an innovative, molecular diagnostics company that has commercialized the MiQLab® System for automated, genetic syndromic